Search

Issue
Title
Authors
Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer (Russian Translation of Cochrane Plain Language Summary)
Staroverova T.A.
Effectiveness and safety of empegfilgrastim (Extimia®, BIOCAD) in patients with lymphoproliferative diseases who receive cytotoxic therapy: results of LEGERITY, the second interim analysis of multicenter retrospective-and-prospective observational post-marketing study
Nesterova E.S., Saydullaeva A.F., Sherstnev D.G., Shelekhova T.V., Klitochenko T.Y., Khusainova G.N., Lysenko I.B., Lyalina I.S., Demchenkova M.V., Orlova S.A., Proydakov A.V., Betrozova M.V., Fadeeva N.V., Gofman A.A., Marchenko Y.M., Voloshin S.V., Pashneva E.A., Sarzhevskiy V.O., Ishchanov D.G., Poddubnaya I.V.
Effectiveness and safety of empegfilgrastim (Extimia®, BIOCAD) in patients with lymphoproliferative diseases receiving cytotoxic therapy: results of LEGERITY, a multicenter retrospective-and-prospective observational post-marketing study
Nesterova E.S., Saydullaeva A.F., Sherstnev D.G., Shelekhova T.V., Klitochenko T.Y., Khusainova G.N., Lysenko I.B., Lyalina I.S., Demchenkova M.V., Orlova S.A., Proydakov A.V., Betrozova М.V., Fadeeva N.V., Gofman A.A., Marchenko Y.M., Voloshin S.V., Pashneva E.A., Sarzhevskiy V.O., Babicheva A.R., Bondareva I.B., Glonina N.N., Ishchanov D.G., Poddubnaya I.V.
Experience in prevention of neutropenia in patients with disseminated soft tissue sarcomas receiving polychemotherapy
Vladimirova L.Y., Mitashok I.S., Snezhko T.A., Samaneva N.Y., Storozhakova A.E., Kornilova I.S.
Prognosticheskie faktory effektivnosti lecheniya retsidiva raka yaichnikov IV stadii
Mel'ko A.I., Ushakov I.I., Kira E.F., Shamkina V.O., Gaytukieva R.A.
Current understanding of the role of insulin-like and vascular endothelial growth factors in development, prognosis and targeted therapy in patients with ovarian cancer
Knyazev R.I., Poddubnaya I.V., Barinov V.V., Bokin I.I.
Primenenie lenograstima (granotsit) v onkologii
Minenko S.V.
Clinical and prognostic significance of matrix metalloproteinase-7 and vascular endothelium growth factor in patients with ovarian cancer
Knyazev R.I., Poddubnaya I.V., Bokin I.I., Barinov V.V.
Fraksiparin kak osnovnoe sredstvo profilaktiki tromboembolii legochnoy arterii v posleoperatsionnom periode u bol'nykh kolorektal'nym rakom
Makarov O.G.
Improving early breast cancer treatment: the role of granulocyte colony-stimulating factor
Ganshina I.P., Ivanova K.A., Lubennikova E.V., Arkhipov A.V., Zhukova L.G.
Avastin in clinical chemotherapy of malignant tumors
Gorbunova V.A.
Nekotorye prognosticheskie faktory pri sovremennoy terapii khronicheskogo limfoleykoza
Byalik T.E., Grivtsova L.Y., Karseladze A.I., Zagoskina T.P., Bessmel'tsev S.S., Volkova M.A.
Interim results of a multicenter retrospective-prospective observational post-marketing study of Extimia® BIOCAD (INN: empegfilgrastim) to evaluate safety and efficacy in patients with lymphoproliferative diseases receiving cytotoxic therapy
Nesterova E.S., Klitochenko T.Y., Glonina N.N., Fadeeva N.V., Sannikova T.A., Lyalina I.S., Shelekhova T.V., Sherstnev D.G., Voloshin S.V., Sarzhevskii V.O., Hofman A.A., Ichshanov D.G., Poddubnaya I.V.
The role of cytokines in the chemotherapy of malignant tumors:the practice of cytokines Refnot® and Ingaron® administration in advanced cancer with multiple metastases
Bryuzgin V.V., Platinskij L.N.
Limfoma Khodzhkina: prognosticheskie priznaki segodnya
Demina E.A.
Reduction of febrile neutropenia by using long-acting granulocyte colony-stimulating factors in patients with solid tumors receiving every-2-week chemotherapy
Kononenko I.B., Snegovoy A.V., Grebennikova O.P., Sel’chuk V.Y., Palchinskaia O.V.
VEGF inhibitors: a new era in the treatment of metastatic ovarian cancer
Pignata S.
Opyt profilakticheskogo primeneniya rekombinantnogo faktora Vila dlya umen'sheniya intraoperatsionnykh krovotecheniy u onkologicheskikh bol'nykh
Barkagan Z.S., Khodorenko S.A., Mamaev A.N., Nazarov A.V., Mamaeva I.V., Tsyvkina L.P., Rossokha A.V.
Meta-analysis of the studies dedicated to the predictive significance of circulating tumor DNA in pancreatic cancer
Popova A.S., Fedyanin M.Y., Pokataev I.A., Tyulyandin S.A.
Klinicheskaya effektivnost'i bezopasnost' primeneniya otechestvennogo rekombinantnogo granulotsitarnogo koloniestimuliruyushchego faktora Neypomaks® u bol'nykh rakom molochnoy zhelezy, poluchayushchikh khimioterapiyu doksorubitsinom i dotsetakselom
Zhukova L.G., Abramov M.E., Vakhabova Y.V., Lud A.N., Obukhov A.A., Lichinitser M.R.
Immuno-morfologicheskie faktory prognoza pri limfome Khodzhkina
Tumyan G.S., Tupitsyn N.N., Probatova N.A., Kovrigina A.M., Sholokhova E.N.
Passive smoking prevalence among patients of krasnoyarsk regional oncologic dispensary
Kutumova O.Y., Kononova L.I., Dobretsova E.A., Shulmin A.B., Korotkova K.M., Rossiyeva T.V.
Kharakteristika granulotsitarnogo koloniestimuliruyushchego faktora: pokazaniya k primeneniyu
Finogenova N.A.
Zavisimost' vozniknoveniya retsidiva raka yaichnika rannikh stadiy ot prognosticheskikh faktorov
Tamaeva Z.E., Zhordania K.I., Kharitonova T.V., Panichenko I.V., Poddubnaya I.V.
1 - 24 of 24 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies